Kathryn A. Gold, M.D. Appointed Chief of the Division of Hematology and Oncology at the UC San Diego, Moores Cancer Center
Dr. Kate Gold has been appointed as Chief of the Division of Hematology and Oncology at Moores Cancer Center. Dr. Gold was selected as interim Chief for the division, after an internal search earlier this year.
Dr. Gold joined UC San Diego in 2016 and has assumed various leadership roles since her arrival, which include UCSD Medical Director of Cancer Quality and Value in 2019 and HS Clinical Professor and UC Health Cancer Quality Improvement Advisor in 2021. Her clinical and research targets thoracic and head and neck malignancies, with an emphasis on targeted therapies and immunotherapies. As a Professor in the UC San Diego, School of Medicine, Department of Medicine, Dr. Gold instructs medical students, residents, and fellows. In addition, Dr. Gold has co-authored many articles, and her research has appeared in The Lancet Oncology , the Journal of the National Cancer Institute , and The New England Journal of Medicine , among others. Moreover, she is a Member of the American Society of Clinical Oncology, the American Association of Cancer Research, and the International Association for the Study of Lung Cancer.
Dr. Gold brings proven leadership from appointments that date back to her fellowship in medical oncology at the University of Texas, MD Anderson Cancer Center, where she was selected for her clinical and leadership abilities to serve as Chief Fellow. She also completed a residency in internal medicine at the Hospital of the University of Pennsylvania in Philadelphia. In addition, she has held several leadership roles at Moores, and she served as the Vice Chief of the Hematology and Oncology Division from 2020, until she was named interim Chief in May of this year.
“We look forward to working closely with Dr. Gold to ensure not only the future success of the division, but also the ongoing collaboration with Moores,” said Joseph Califano, MD, Director of Moores Cancer Center at UC San Diego Health.
About Moores Cancer Center
Established in 1978, the UC San Diego, Moores Cancer Center is not only one of just 53 National Cancer Institute (NCI) designated Comprehensive Cancer Centers in the United States, but also the only one operating in the San Diego region. Moores Cancer Center delivers discoveries from the laboratories of UC San Diego, La Jolla Institute for Immunology, and San Diego State University, through the highly ranked cancer services of UC San Diego Health. Studies show that outcomes are better at NCI-designated Comprehensive Cancer Centers. Indeed, the cancer services of UC San Diego Health have been ranked #1 in San Diego, with 10 specialties ranking nationally, by U.S. News & World Report, as reported in its 2022–2023 "Best Hospitals" survey.